Making adjuvant therapy decisions with uncertain data

B. Gyawali; V. Prasad

doi:10.1093/annonc/mdz039

Making adjuvant therapy decisions with uncertain data

B. Gyawali, V. Prasad

Knight Cancer Institute

Research output: Contribution to journal › Editorial › peer-review

9 Scopus citations

Original language	English (US)
Pages (from-to)	361-364
Number of pages	4
Journal	Annals of Oncology
Volume	30
Issue number	3
DOIs	https://doi.org/10.1093/annonc/mdz039
State	Published - Mar 1 2019

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdz039

Cite this

@article{0b5643fef5774d27aa79042f16864876,

title = "Making adjuvant therapy decisions with uncertain data",

author = "B. Gyawali and V. Prasad",

note = "Funding Information: VP reports receiving royalties from his book Ending Medical Reversal; that his work is funded by the Laura and John Arnold Foundation; that he has received honoraria for Grand Rounds/ lectures from several universities, medical centers, and professional societies and payments for contributions to Medscape. BG has declared no conflicts of interest. Funding Information: The TH lab is primarily funded by the University of Sheffield, Swedish Research Council, ERC (695376-TAROX), and the Swedish Cancer Society.",

year = "2019",

month = mar,

day = "1",

doi = "10.1093/annonc/mdz039",

language = "English (US)",

volume = "30",

pages = "361--364",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - Making adjuvant therapy decisions with uncertain data

AU - Gyawali, B.

AU - Prasad, V.

N1 - Funding Information: VP reports receiving royalties from his book Ending Medical Reversal; that his work is funded by the Laura and John Arnold Foundation; that he has received honoraria for Grand Rounds/ lectures from several universities, medical centers, and professional societies and payments for contributions to Medscape. BG has declared no conflicts of interest. Funding Information: The TH lab is primarily funded by the University of Sheffield, Swedish Research Council, ERC (695376-TAROX), and the Swedish Cancer Society.

PY - 2019/3/1

Y1 - 2019/3/1

UR - http://www.scopus.com/inward/record.url?scp=85064109578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064109578&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdz039

DO - 10.1093/annonc/mdz039

M3 - Editorial

C2 - 30715160

AN - SCOPUS:85064109578

SN - 0923-7534

VL - 30

SP - 361

EP - 364

JO - Annals of Oncology

JF - Annals of Oncology

IS - 3

ER -

Making adjuvant therapy decisions with uncertain data

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this